CellCentric vs Poplar Therapeutics

CellCentric vs Poplar Therapeutics, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CellCentric is on 60/100 and Poplar Therapeutics on 51/100.

CellCentric logo
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Try CellCentric
Poplar Therapeutics logo
Poplar TherapeuticsDeveloping a new class of anti-IgE therapy for multiple atopic conditions.
Try Poplar Therapeutics

Where each one leads

CellCentric

  • our overall score: 60/100 against 51/100
  • domain rating: 35/100 against 4/100
  • headcount: 53 against 15
  • funding raised: $375M against $50.0M
  • LinkedIn following: 28,695 against 1,205

Poplar Therapeutics

  • agent readiness: 40/100 against 32/100

At a glance

MeasureCellCentricPoplar Therapeutics
What it isA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.Developing a new class of anti-IgE therapy for multiple atopic conditions.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Pharmaceuticals, HealthTech, Biotech
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20032021
HeadquartersCambridge, United KingdomBoston, USA
StatusActiveActive

Size, funding and growth

MeasureCellCentricPoplar Therapeutics
Employees5315
Total funding$375M$50.0M
Latest roundSeries DSeries A
LinkedIn followers28,6951,205

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellCentricPoplar Therapeutics
StartupHub scoreOur 0-100 rating60/10051/100
Traction57/10051/100
Team60/10030/100
Search visibility44/10025/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)D (40/100)
Domain ratingLink authority, 0-10035/1004/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellCentricPoplar Therapeutics
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4Google Analytics 4

CellCentric vs Poplar Therapeutics: common questions

Which is better, CellCentric or Poplar Therapeutics?

On our 0-100 score CellCentric rates higher (60/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.

How do CellCentric and Poplar Therapeutics compare on the numbers?

CellCentric leads on our overall score (60/100 against 51/100), domain rating (35/100 against 4/100), headcount (53 against 15), funding raised ($375M against $50.0M), LinkedIn following (28,695 against 1,205). Poplar Therapeutics leads on agent readiness (40/100 against 32/100).

Read the full CellCentric review and pricing or the Poplar Therapeutics review and pricing. You can also browse other CellCentric alternatives we track.